Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis. | Gut Microbes | 2024 | 38214604 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma. | Eur Respir J | 2024 | 38212075 | PubTator, text mining | PubMed |
| The chromatin landscape of healthy and injured cell types in the human kidney. | Nat Commun | 2024 | 38199997 | PubTator, text mining | PubMed |
| Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity. | J Invest Dermatol | 2024 | 38157931 | PubTator, text mining | PubMed |
| Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative Breast Cancer. | Mol Cell Proteomics | 2024 | 38128647 | PubTator, text mining | PubMed |
| Release of miR-29 Target Laminin C2 Improves Skin Repair. | Am J Pathol | 2024 | 37981221 | PubTator, text mining | PubMed |
| LAMC2 mitigates ER stress by enhancing ER-mitochondria interaction via binding to MYH9 and MYH10. | Cancer Gene Ther | 2024 | 37891404 | PubTator, text mining | PubMed |
| Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. | Cancer Res Treat | 2024 | 37697729 | PubTator, text mining | PubMed |
| LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma. | Biochem Genet | 2024 | 37382751 | PubTator, text mining | PubMed |
| The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery. | Biomedicines | 2023 | 38255186 | PubTator, text mining | PubMed |
| Leveraging technology-driven strategies to untangle omics big data: circumventing roadblocks in clinical facets of oral cancer. | Front Oncol | 2023 | 38234400 | PubTator, text mining | PubMed |
| Revolutionizing Cancer Treatment: Unveiling New Frontiers by Targeting the (Un)Usual Suspects. | Cancers (Basel) | 2023 | 38201558 | PubTator, text mining | PubMed |
| Identification of the function of FOSB in cholangiocarcinoma using bioinformatics analysis. | Transl Cancer Res | 2023 | 38192979 | PubTator, text mining | PubMed |
| The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features. | Front Pharmacol | 2023 | 38178861 | PubTator, text mining | PubMed |
| Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis. | Front Oncol | 2023 | 38144520 | PubTator, text mining | PubMed |
| Insights into the Tumor Microenvironment-Components, Functions and Therapeutics. | Int J Mol Sci | 2023 | 38139365 | PubTator, text mining | PubMed |
| Androgen Receptor/AP-1 Activates UGT2B15 Transcription to Promote Esophageal Squamous Cell Carcinoma Invasion. | Cancers (Basel) | 2023 | 38136265 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder. | J Neuroinflammation | 2023 | 38129902 | PubTator, text mining | PubMed |
| Exosome-based engineering strategies for the diagnosis and treatment of oral and maxillofacial diseases. | J Nanobiotechnology | 2023 | 38129853 | PubTator, text mining | PubMed |
| Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. | Sci Rep | 2023 | 38114514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=8